# ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)

> **NCT03322696** · — · UNKNOWN · sponsor: **Raimondo De Cristofaro** · enrollment: 118 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03322696
- **Lead sponsor:** Raimondo De Cristofaro
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03322696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03322696, "ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03322696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*